AdaptHealth Corp. (NASDAQ: AHCO) Stock Competitors & Peer Comparison
See AHCO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AHCO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AHCO | $5.70 | -1.21% | 775.5M | 11.63 | $0.49 | N/A |
| ABT | $103.49 | -0.23% | 179.1B | 19.87 | $5.21 | +2.40% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $89.30 | -1.62% | 114.3B | 16.15 | $5.53 | +3.21% |
| SYK | $273.40 | -0.61% | 104.8B | 20.42 | $13.39 | +1.28% |
| BSX | $44.62 | -0.67% | 66.4B | 14.40 | $3.10 | N/A |
| EW | $86.82 | -2.21% | 50B | 32.15 | $2.70 | N/A |
| DXCM | $87.73 | -2.01% | 33.1B | 34.40 | $2.55 | N/A |
| GEHC | $66.09 | -0.27% | 29.9B | 14.49 | $4.56 | +0.21% |
| PHG | $24.45 | -2.08% | 23.9B | 13.97 | $1.75 | +4.04% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
AHCO vs ABT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ABT has a market cap of 179.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ABT trades at $103.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ABT's P/E ratio is 19.87. In terms of profitability, AHCO's ROE is -0.15%, compared to ABT's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
AHCO vs BSX-PA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, AHCO's ROE is -0.15%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
AHCO vs MDT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, MDT has a market cap of 114.3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while MDT trades at $89.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas MDT's P/E ratio is 16.15. In terms of profitability, AHCO's ROE is -0.15%, compared to MDT's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
AHCO vs SYK Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SYK has a market cap of 104.8B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SYK trades at $273.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SYK's P/E ratio is 20.42. In terms of profitability, AHCO's ROE is -0.15%, compared to SYK's ROE of +0.16%. Regarding short-term risk, AHCO is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
AHCO vs BSX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BSX has a market cap of 66.4B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BSX trades at $44.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BSX's P/E ratio is 14.40. In terms of profitability, AHCO's ROE is -0.15%, compared to BSX's ROE of +0.15%. Regarding short-term risk, AHCO is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
AHCO vs EW Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, EW has a market cap of 50B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while EW trades at $86.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas EW's P/E ratio is 32.15. In terms of profitability, AHCO's ROE is -0.15%, compared to EW's ROE of +0.10%. Regarding short-term risk, AHCO is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
AHCO vs DXCM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, DXCM has a market cap of 33.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while DXCM trades at $87.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas DXCM's P/E ratio is 34.40. In terms of profitability, AHCO's ROE is -0.15%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, AHCO is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
AHCO vs GEHC Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, GEHC has a market cap of 29.9B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while GEHC trades at $66.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas GEHC's P/E ratio is 14.49. In terms of profitability, AHCO's ROE is -0.15%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
AHCO vs PHG Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, PHG has a market cap of 23.9B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while PHG trades at $24.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas PHG's P/E ratio is 13.97. In terms of profitability, AHCO's ROE is -0.15%, compared to PHG's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
AHCO vs ZBH Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ZBH trades at $90.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ZBH's P/E ratio is 10.72. In terms of profitability, AHCO's ROE is -0.15%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, AHCO is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
AHCO vs ABMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ABMD's P/E ratio is 65.36. In terms of profitability, AHCO's ROE is -0.15%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
AHCO vs PEN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while PEN trades at $319.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas PEN's P/E ratio is 83.37. In terms of profitability, AHCO's ROE is -0.15%, compared to PEN's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
AHCO vs SWAV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SWAV's P/E ratio is 78.76. In terms of profitability, AHCO's ROE is -0.15%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, AHCO is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
AHCO vs SNN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SNN trades at $26.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SNN's P/E ratio is 18.10. In terms of profitability, AHCO's ROE is -0.15%, compared to SNN's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
AHCO vs ALGN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ALGN has a market cap of 10.6B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ALGN trades at $148.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ALGN's P/E ratio is 13.51. In terms of profitability, AHCO's ROE is -0.15%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, AHCO is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
AHCO vs BIO-B Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BIO-B has a market cap of 10.3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BIO-B trades at $374.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BIO-B's P/E ratio is -65.99. In terms of profitability, AHCO's ROE is -0.15%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, AHCO is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
AHCO vs BIO Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BIO trades at $378.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BIO's P/E ratio is 40.83. In terms of profitability, AHCO's ROE is -0.15%, compared to BIO's ROE of +0.03%. Regarding short-term risk, AHCO is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
AHCO vs GMED Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, GMED has a market cap of 10B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while GMED trades at $73.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas GMED's P/E ratio is 16.66. In terms of profitability, AHCO's ROE is -0.15%, compared to GMED's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check GMED's competition here
Insulet Corp. (NASDAQ: PODD)
AHCO vs PODD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, PODD has a market cap of 9.5B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while PODD trades at $136.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas PODD's P/E ratio is 23.25. In terms of profitability, AHCO's ROE is -0.15%, compared to PODD's ROE of +0.27%. Regarding short-term risk, AHCO is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
AHCO vs MASI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas MASI's P/E ratio is 44.43. In terms of profitability, AHCO's ROE is -0.15%, compared to MASI's ROE of +0.09%. Regarding short-term risk, AHCO is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
AHCO vs BRKR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BRKR has a market cap of 9.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BRKR trades at $59.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BRKR's P/E ratio is 29.98. In terms of profitability, AHCO's ROE is -0.15%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, AHCO is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BRKR's competition here
Glaukos Corporation (NYSE: GKOS)
AHCO vs GKOS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while GKOS trades at $153.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas GKOS's P/E ratio is -178.48. In terms of profitability, AHCO's ROE is -0.15%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, AHCO is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check GKOS's competition here
Bruker Corporation (NASDAQ: BRKRP)
AHCO vs BRKRP Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BRKRP has a market cap of 8.8B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BRKRP trades at $439.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BRKRP's P/E ratio is 238.95. In terms of profitability, AHCO's ROE is -0.15%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, AHCO is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
AHCO vs HAE Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while HAE trades at $106.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas HAE's P/E ratio is 21.32. In terms of profitability, AHCO's ROE is -0.15%, compared to HAE's ROE of +0.11%. Regarding short-term risk, AHCO is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
AHCO vs NARI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas NARI's P/E ratio is -59.24. In terms of profitability, AHCO's ROE is -0.15%, compared to NARI's ROE of -0.00%. Regarding short-term risk, AHCO is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
AHCO vs ITGR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ITGR trades at $126.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ITGR's P/E ratio is 19.89. In terms of profitability, AHCO's ROE is -0.15%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, AHCO is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
AHCO vs LIVN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while LIVN trades at $77.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas LIVN's P/E ratio is 18.33. In terms of profitability, AHCO's ROE is -0.15%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, AHCO is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
AHCO vs IRTC Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, IRTC has a market cap of 3.7B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while IRTC trades at $111.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas IRTC's P/E ratio is -259.88. In terms of profitability, AHCO's ROE is -0.15%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, AHCO is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
AHCO vs AXNX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas AXNX's P/E ratio is -709.80. In terms of profitability, AHCO's ROE is -0.15%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, AHCO is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
AHCO vs TMDX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while TMDX trades at $87.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas TMDX's P/E ratio is 44.16. In terms of profitability, AHCO's ROE is -0.15%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, AHCO is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
AHCO vs NEOG Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while NEOG trades at $13.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas NEOG's P/E ratio is 48.46. In terms of profitability, AHCO's ROE is -0.15%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, AHCO is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check NEOG's competition here
Butterfly Network, Inc. (NYSE: BFLY)
AHCO vs BFLY Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BFLY trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BFLY's P/E ratio is -38.31. In terms of profitability, AHCO's ROE is -0.15%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, AHCO is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
AHCO vs AXGN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while AXGN trades at $43.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas AXGN's P/E ratio is 114.00. In terms of profitability, AHCO's ROE is -0.15%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, AHCO is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
AHCO vs UFPT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while UFPT trades at $287.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas UFPT's P/E ratio is 29.35. In terms of profitability, AHCO's ROE is -0.15%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, AHCO is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
AHCO vs NUVA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas NUVA's P/E ratio is 75.00. In terms of profitability, AHCO's ROE is -0.15%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, AHCO is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
AHCO vs INSP Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while INSP trades at $69.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas INSP's P/E ratio is 30.41. In terms of profitability, AHCO's ROE is -0.15%, compared to INSP's ROE of +0.18%. Regarding short-term risk, AHCO is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
AHCO vs ESTA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ESTA trades at $67.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ESTA's P/E ratio is -53.78. In terms of profitability, AHCO's ROE is -0.15%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, AHCO is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
AHCO vs NVCR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while NVCR trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas NVCR's P/E ratio is -12.50. In terms of profitability, AHCO's ROE is -0.15%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, AHCO is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
AHCO vs ATEC Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ATEC trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ATEC's P/E ratio is -167.17. In terms of profitability, AHCO's ROE is -0.15%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, AHCO is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
AHCO vs CNMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CNMD trades at $45.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CNMD's P/E ratio is 10.07. In terms of profitability, AHCO's ROE is -0.15%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, AHCO is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
AHCO vs HSKA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas HSKA's P/E ratio is -62.49. In terms of profitability, AHCO's ROE is -0.15%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, AHCO is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
AHCO vs IART Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while IART trades at $15.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas IART's P/E ratio is 6.58. In terms of profitability, AHCO's ROE is -0.15%, compared to IART's ROE of -0.01%. Regarding short-term risk, AHCO is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
AHCO vs AVNS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas AVNS's P/E ratio is 27.77. In terms of profitability, AHCO's ROE is -0.15%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, AHCO is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check AVNS's competition here
Artivion, Inc. (NYSE: AORT)
AHCO vs AORT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while AORT trades at $23.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas AORT's P/E ratio is 39.20. In terms of profitability, AHCO's ROE is -0.15%, compared to AORT's ROE of -0.01%. Regarding short-term risk, AHCO is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check AORT's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
AHCO vs TNDM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while TNDM trades at $16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas TNDM's P/E ratio is -17.61. In terms of profitability, AHCO's ROE is -0.15%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, AHCO is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
AHCO vs SILK Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SILK's P/E ratio is -18.96. In terms of profitability, AHCO's ROE is -0.15%, compared to SILK's ROE of -0.35%. Regarding short-term risk, AHCO is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
AHCO vs IRMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while IRMD trades at $86.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas IRMD's P/E ratio is 43.39. In terms of profitability, AHCO's ROE is -0.15%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, AHCO is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
AHCO vs FNA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas FNA's P/E ratio is -19.83. In terms of profitability, AHCO's ROE is -0.15%, compared to FNA's ROE of -0.35%. Regarding short-term risk, AHCO is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
AHCO vs ENOV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ENOV trades at $18.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ENOV's P/E ratio is 5.22. In terms of profitability, AHCO's ROE is -0.15%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, AHCO is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
AHCO vs PRCT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while PRCT trades at $18.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas PRCT's P/E ratio is -9.32. In terms of profitability, AHCO's ROE is -0.15%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, AHCO is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PRCT's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
AHCO vs BBNX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BBNX has a market cap of 998.3M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BBNX trades at $22.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BBNX's P/E ratio is -13.45. In terms of profitability, AHCO's ROE is -0.15%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, AHCO is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BBNX's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
AHCO vs LMRI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, LMRI has a market cap of 974.3M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while LMRI trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas LMRI's P/E ratio is -19.73. In terms of profitability, AHCO's ROE is -0.15%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, AHCO is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
AHCO vs BVS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BVS has a market cap of 922.1M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BVS trades at $13.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BVS's P/E ratio is 17.91. In terms of profitability, AHCO's ROE is -0.15%, compared to BVS's ROE of +0.28%. Regarding short-term risk, AHCO is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
AHCO vs CBLL Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CBLL has a market cap of 896.2M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CBLL trades at $23.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CBLL's P/E ratio is -13.42. In terms of profitability, AHCO's ROE is -0.15%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, AHCO is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CBLL's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
AHCO vs CSII Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CSII's P/E ratio is -20.83. In terms of profitability, AHCO's ROE is -0.15%, compared to CSII's ROE of -0.14%. Regarding short-term risk, AHCO is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
AHCO vs SIBN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SIBN has a market cap of 824.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SIBN trades at $18.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SIBN's P/E ratio is -54.71. In terms of profitability, AHCO's ROE is -0.15%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, AHCO is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
AHCO vs INMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, INMD has a market cap of 815.7M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while INMD trades at $14.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas INMD's P/E ratio is 9.85. In terms of profitability, AHCO's ROE is -0.15%, compared to INMD's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
AHCO vs VREX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas VREX's P/E ratio is 19.42. In terms of profitability, AHCO's ROE is -0.15%, compared to VREX's ROE of +0.05%. Regarding short-term risk, AHCO is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check VREX's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
AHCO vs AVR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, AVR has a market cap of 740.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while AVR trades at $7.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas AVR's P/E ratio is -3.93. In terms of profitability, AHCO's ROE is -0.15%, compared to AVR's ROE of -0.78%. Regarding short-term risk, AHCO is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
AHCO vs CTKB Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CTKB has a market cap of 733.5M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CTKB trades at $5.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CTKB's P/E ratio is -30.09. In terms of profitability, AHCO's ROE is -0.15%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, AHCO is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CTKB's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
AHCO vs SSII Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SSII has a market cap of 622.4M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SSII trades at $3.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SSII's P/E ratio is -51.83. In terms of profitability, AHCO's ROE is -0.15%, compared to SSII's ROE of -0.27%. Regarding short-term risk, AHCO is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
AHCO vs SRDX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SRDX's P/E ratio is -34.66. In terms of profitability, AHCO's ROE is -0.15%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, AHCO is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
AHCO vs APEN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas APEN's P/E ratio is -9.43. In terms of profitability, AHCO's ROE is -0.15%, compared to APEN's ROE of -0.85%. Regarding short-term risk, AHCO is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
AHCO vs KIDS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, KIDS has a market cap of 573.5M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while KIDS trades at $22.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas KIDS's P/E ratio is -18.92. In terms of profitability, AHCO's ROE is -0.15%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, AHCO is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
AHCO vs DCTH Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, DCTH has a market cap of 551M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while DCTH trades at $15.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas DCTH's P/E ratio is 1596.00. In terms of profitability, AHCO's ROE is -0.15%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, AHCO is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
AHCO vs ZIMV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, AHCO's ROE is -0.15%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, AHCO is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
AHCO vs CERS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CERS has a market cap of 524M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CERS trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CERS's P/E ratio is -86.38. In terms of profitability, AHCO's ROE is -0.15%, compared to CERS's ROE of -0.10%. Regarding short-term risk, AHCO is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
AHCO vs TCMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, TCMD has a market cap of 505.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while TCMD trades at $22.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas TCMD's P/E ratio is 20.77. In terms of profitability, AHCO's ROE is -0.15%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
AHCO vs NPCE Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, NPCE has a market cap of 484.5M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while NPCE trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas NPCE's P/E ratio is -24.93. In terms of profitability, AHCO's ROE is -0.15%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, AHCO is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
AHCO vs SGHT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SGHT has a market cap of 462.5M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SGHT trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SGHT's P/E ratio is -15.18. In terms of profitability, AHCO's ROE is -0.15%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, AHCO is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SGHT's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
AHCO vs CLPT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CLPT has a market cap of 448.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CLPT trades at $14.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CLPT's P/E ratio is -12.69. In terms of profitability, AHCO's ROE is -0.15%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, AHCO is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CLPT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
AHCO vs PACB Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, PACB has a market cap of 437.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while PACB trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas PACB's P/E ratio is -3.44. In terms of profitability, AHCO's ROE is -0.15%, compared to PACB's ROE of -49.62%. Regarding short-term risk, AHCO is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PACB's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
AHCO vs SENS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SENS has a market cap of 416.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SENS trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SENS's P/E ratio is -4.47. In terms of profitability, AHCO's ROE is -0.15%, compared to SENS's ROE of -1.66%. Regarding short-term risk, AHCO is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
AHCO vs OFIX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, OFIX has a market cap of 371.1M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while OFIX trades at $9.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas OFIX's P/E ratio is -5.98. In terms of profitability, AHCO's ROE is -0.15%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, AHCO is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
AHCO vs SMLR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas SMLR's P/E ratio is 3.92. In terms of profitability, AHCO's ROE is -0.15%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, AHCO is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SMLR's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
AHCO vs TLSI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, TLSI has a market cap of 307.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while TLSI trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas TLSI's P/E ratio is -2.98. In terms of profitability, AHCO's ROE is -0.15%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, AHCO is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
AHCO vs CV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CV has a market cap of 302.3M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CV trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CV's P/E ratio is -9.60. In terms of profitability, AHCO's ROE is -0.15%, compared to CV's ROE of -1.78%. Regarding short-term risk, AHCO is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CV's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
AHCO vs CATX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, CATX has a market cap of 298.4M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while CATX trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas CATX's P/E ratio is -1.97. In terms of profitability, AHCO's ROE is -0.15%, compared to CATX's ROE of -0.42%. Regarding short-term risk, AHCO is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CATX's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
AHCO vs TMCI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas TMCI's P/E ratio is -4.80. In terms of profitability, AHCO's ROE is -0.15%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, AHCO is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TMCI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
AHCO vs RCEL Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, RCEL has a market cap of 272M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while RCEL trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas RCEL's P/E ratio is -7.60. In terms of profitability, AHCO's ROE is -0.15%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, AHCO is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
AHCO vs INFU Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, INFU has a market cap of 257.5M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while INFU trades at $12.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas INFU's P/E ratio is 31.12. In terms of profitability, AHCO's ROE is -0.15%, compared to INFU's ROE of +0.15%. Regarding short-term risk, AHCO is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
AHCO vs MGRM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas MGRM's P/E ratio is -12.00. In terms of profitability, AHCO's ROE is -0.15%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, AHCO is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
AHCO vs ELMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ELMD has a market cap of 229.8M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ELMD trades at $27.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ELMD's P/E ratio is 21.18. In terms of profitability, AHCO's ROE is -0.15%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, AHCO is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
AHCO vs NVRO Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas NVRO's P/E ratio is -1.91. In terms of profitability, AHCO's ROE is -0.15%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, AHCO is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
AHCO vs PROF Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, PROF has a market cap of 208.4M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while PROF trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas PROF's P/E ratio is -5.85. In terms of profitability, AHCO's ROE is -0.15%, compared to PROF's ROE of -0.56%. Regarding short-term risk, AHCO is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
AHCO vs RXST Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, RXST has a market cap of 200.8M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while RXST trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas RXST's P/E ratio is -4.29. In terms of profitability, AHCO's ROE is -0.15%, compared to RXST's ROE of -0.17%. Regarding short-term risk, AHCO is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check RXST's competition here
Neuronetics, Inc. (NASDAQ: STIM)
AHCO vs STIM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, STIM has a market cap of 200.4M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while STIM trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas STIM's P/E ratio is -6.55. In terms of profitability, AHCO's ROE is -0.15%, compared to STIM's ROE of -1.51%. Regarding short-term risk, AHCO is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
AHCO vs BSGM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas BSGM's P/E ratio is -5.81. In terms of profitability, AHCO's ROE is -0.15%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, AHCO is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
AHCO vs MDGS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas MDGS's P/E ratio is -0.27. In terms of profitability, AHCO's ROE is -0.15%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, AHCO is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
AHCO vs FOCL Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, FOCL has a market cap of 177.7M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while FOCL trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas FOCL's P/E ratio is -4.58. In terms of profitability, AHCO's ROE is -0.15%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, AHCO is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
AHCO vs QIPT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas QIPT's P/E ratio is -15.87. In terms of profitability, AHCO's ROE is -0.15%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, AHCO is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
AHCO vs LUCD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, LUCD has a market cap of 160M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while LUCD trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas LUCD's P/E ratio is -2.27. In terms of profitability, AHCO's ROE is -0.15%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, AHCO is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check LUCD's competition here
Quantum-Si incorporated (NASDAQ: QSI)
AHCO vs QSI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, QSI has a market cap of 150.1M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while QSI trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas QSI's P/E ratio is -1.65. In terms of profitability, AHCO's ROE is -0.15%, compared to QSI's ROE of -0.47%. Regarding short-term risk, AHCO is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check QSI's competition here
Quanterix Corporation (NASDAQ: QTRX)
AHCO vs QTRX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, QTRX has a market cap of 148.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while QTRX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas QTRX's P/E ratio is -1.24. In terms of profitability, AHCO's ROE is -0.15%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, AHCO is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
AHCO vs INGN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, INGN has a market cap of 137.8M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while INGN trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas INGN's P/E ratio is -5.59. In terms of profitability, AHCO's ROE is -0.15%, compared to INGN's ROE of -0.13%. Regarding short-term risk, AHCO is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
AHCO vs ICAD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ICAD's P/E ratio is -20.37. In terms of profitability, AHCO's ROE is -0.15%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, AHCO is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
AHCO vs ECOR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ECOR has a market cap of 103M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ECOR trades at $11.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ECOR's P/E ratio is -6.80. In terms of profitability, AHCO's ROE is -0.15%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, AHCO is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
AHCO vs HJLI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas HJLI's P/E ratio is N/A. In terms of profitability, AHCO's ROE is -0.15%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, AHCO is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
AHCO vs ASXC Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 775.5M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, AHCO is priced at $5.70 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 11.63, whereas ASXC's P/E ratio is -1.12. In terms of profitability, AHCO's ROE is -0.15%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, AHCO is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ASXC's competition here